H.R. 8358119th CongressIn committeeLatest action Apr 16, 2026Decoded by AI · checked against the record
Official title: Breast Cancer Research Stamp Reauthorization Act of 2026
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
HR 8358 extends the breast cancer research postage stamp program for ten more years, moving its end date from 2027 to 2037.
30-second read · 4 questions answered below
This bill renews a special U.S. Postal Service stamp that raises money for breast cancer research. The stamp is sold at a higher price than regular postage, and the extra amount goes toward that research. The bill moves the program's expiration date from 2027 to 2037.
Anyone who buys and uses this stamp contributes to breast cancer research funding through their regular postage purchases.
Without this extension, the program would end in 2027. Passing the bill allows the stamp to keep being sold for an additional ten years.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.